These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11535886)

  • 1. Recombinant activated factor VII for adjunctive hemorrhage control in trauma.
    Martinowitz U; Kenet G; Segal E; Luboshitz J; Lubetsky A; Ingerslev J; Lynn M
    J Trauma; 2001 Sep; 51(3):431-8; discussion 438-9. PubMed ID: 11535886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.
    Martinowitz U; Holcomb JB; Pusateri AE; Stein M; Onaca N; Freidman M; Macaitis JM; Castel D; Hedner U; Hess JR
    J Trauma; 2001 Apr; 50(4):721-9. PubMed ID: 11303171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
    Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
    Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.
    Martinowitz U; Michaelson M;
    J Thromb Haemost; 2005 Apr; 3(4):640-8. PubMed ID: 15842347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy.
    McMullin NR; Kauvar DS; Currier HM; Baskin TW; Pusateri AE; Holcomb JB
    Curr Surg; 2006; 63(4):246-51. PubMed ID: 16843774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated coagulation factor VII and bleeding trauma patients.
    Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
    J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant activated factor VII for the treatment of life-threatening haemorrhage.
    Eikelboom JW; Bird R; Blythe D; Coyle L; Gan E; Harvey M; Isbister J; Leahy M; McIlroy D; Rahimpanah F; Ramanthan S; Strasser S; Ward C; Watts A; Towler S; Yi Q
    Blood Coagul Fibrinolysis; 2003 Dec; 14(8):713-7. PubMed ID: 14614349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.
    Mohr AM; Holcomb JB; Dutton RP; Duranteau J
    Crit Care; 2005; 9 Suppl 5(Suppl 5):S37-42. PubMed ID: 16221318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation.
    Gerotziafas GT; Zervas K; Arzoglou P; Karavaggeli E; Parashou S; Van Dreden P; Christakis J; Samama MM
    Br J Haematol; 2002 Jun; 117(3):705-8. PubMed ID: 12028045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant activated factor VII increases survival time in a model of incompressible arterial hemorrhage in the anesthetized pig.
    Sapsford W; Watts S; Cooper G; Kirkman E
    J Trauma; 2007 Apr; 62(4):868-79. PubMed ID: 17426541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
    Shamsi T; Tufail M; Aftab M; Ansari S
    J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant FVIIa in hypothermic, coagulopathic pigs with liver injuries.
    Klemcke HG; Delgado A; Holcomb JB; Ryan KL; Burke A; DeGuzman R; Scherer M; Cortez D; Uscilowicz J; Macaitis JM; Bliss J; Wojtaszczyk J; Christensen S; Currier H; Pusateri AE
    J Trauma; 2005 Jul; 59(1):155-61; discussion 161. PubMed ID: 16096556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
    Grinţescu I; Tulbure D; Mirea L
    Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant factor VIIa for adjunctive hemorrhage control in trauma and surgical patients.
    Benharash P; Bongard F; Putnam B
    Am Surg; 2005 Sep; 71(9):776-80. PubMed ID: 16468517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII.
    Liebman HA; Chediak J; Fink KI; Galvez AG; Shah PC; Sham RL
    Am J Hematol; 2000 Mar; 63(3):109-13. PubMed ID: 10679799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
    Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.